Every Form 4 that Onconetix, Inc. (ONCO) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow ONCO and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ONCO filings page.
HRT Financial LP, a ten percent owner of Onconetix, Inc., reported an open-market sale of 49,710 Class A Shares at $0.69 per share. After this transaction, HRT Financial LP directly holds 33,649 Class A Shares of Onconetix.
This Form 4 reflects a net reduction in HRT Financial LP’s position, with no derivative securities reported as remaining holdings in this filing.
HRT Financial LP, a ten percent owner of Onconetix, Inc., reported several open-market trades in Class A Shares. On April 16, 2026 and April 20, 2026 it sold a total of 148,329 shares at about $0.73–$0.75 per share, and on April 17, 2026 it purchased 34,636 shares at $0.73. Overall, this was a net sale of 113,693 shares, leaving HRT Financial LP with 83,359 Class A Shares held directly after the last reported transaction.
Onconetix, Inc. major holder HRT FINANCIAL LP increased its stake with open-market purchases of Class A Shares. The investor bought 92,554 shares at $0.76 per share on April 15, 2026 and 74,350 shares at $0.77 per share on April 14, 2026. After these transactions, HRT FINANCIAL LP directly holds 197,052 Class A Shares, reflecting net buying activity over the two days.